H-YASESMSGIPSR-OH

Ref. 3D-PP47208

Produktinformation

• Name: H-YASESMSGIPSR-OH

Beschreibung

Peptide H-YASESMSGIPSR-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-YASESMSGIPSR-OH include the following: Improving Sensitivity in Bioanalysis using Trap-and-Elute MicroLC-MS R van Soest, L Xiong - sciex.jphttps://sciex.jp/content/dam/SCIEX/pdf/tech-notes/all/m3_Bioanalysis_Trap-n-Elute_MicroLC-MS.pdf Improved sensitivity for LC-MS quantitation of biologics in plasma using Trap-and-Elute MicroLC-MS R van Soest, K Motamedchaboki , S Heidelberger - sciex.jphttps://sciex.jp/content/dam/SCIEX/pdf/posters/asms2017/clinical/657_van%20Soest.pdf Verification between original and biosimilar therapeutic antibody infliximab using nSMOL coupled LC-MS bioanalysis in human serum N Iwamoto, K Yokoyama, M Takanashi - Current , 2018 - ingentaconnect.comhttps://www.ingentaconnect.com/content/ben/cpb/2018/00000019/00000006/art00007 Analysis of tryptic peptides from therapeutic monoclonal antibodies using LC-MS/MS MAV Willrich - LC-MS in Drug Analysis: Methods and Protocols, 2019 - Springerhttps://link.springer.com/protocol/10.1007/978-1-4939-8823-5_9 An automated mass spectrometric blood test for therapeutic drug monitoring of infliximab JG van der Gugten , B Bressler, ML DeMarco - Clinical Mass Spectrometry, 2019 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S2376999818300291 Optimization of a Quantitative Anti-Drug Antibodies against Infliximab Assay with the Liquid Chromatography-Tandem Mass Spectrometry: A Method Validation Study EH Smeijsters, KCM van der Elst, A Visch, C Göbel - Pharmaceutics, 2023 - mdpi.comhttps://www.mdpi.com/1999-4923/15/5/1477 MSACL 2023 Abstract (s) for Proteomics D Qasrawi - msacl.orghttps://www.msacl.org/program/view_abstract_selection.php?topic=Proteomics&event=2023 A Robust and Generic Method for Quantification of Monoclonal Antibody Therapeutics in Biological Matrices C Liu , I Moore, W Woroniecki, L Xiong, HF Liu, G Impey - sciex.comhttps://www.sciex.com/content/dam/SCIEX/pdf/tech-notes/all/BioBA-Robust_Method_Quant_mAb_Therapeutics.pdf

• Marke: Biosynth